Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari(Piedmont Atlanta Hospital), Denise Reedus, Sidney A. Cohen(University of Pennsylvania), Michael Böhm(Saarland University), Manesh R. Patel(Duke University), Kazuomi Kario(University of Pennsylvania), David P. Lee(APLA Health), Stuart Pocock(London School of Hygiene & Tropical Medicine), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Felix Mahfoud(University of Basel), Susan Steigerwalt, Garrett Pilcher(Medtronic (United States)), Michael A. Weber(SUNY Downstate Health Sciences University), Vasilios Papademetriou(Hippocration General Hospital), Antony Walton, Raymond R. Townsend(University of Pennsylvania), Roland E. Schmieder(Universitätsklinikum Erlangen), Debbie L. Cohen(University of Pennsylvania), George Dangas(Mount Sinai Hospital), Cara East(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Kiritkumar Patel, Martin Fahy(Medtronic (United States)), Konstantinos Tsioufis(National and Kapodistrian University of Athens), Neil Chapman, Philipp Lurz(Johannes Gutenberg University Mainz), Thomas Zeller(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Janice P. Lea, Jasvindar Singh, Jiro Aoki, Chandan Devireddy, Thomas Weber(Klinikum Wels-Grieskirchen), David Kandzari(Piedmont Atlanta Hospital), Shukri David(Piedmont Atlanta Hospital), Kengo Tanabe, Sandeep Brar(Medtronic (United States)), Robert B. Wilkins, Andrew S.P. Sharp, Justin E. Davies(Lung Institute), Robert Wilensky, Dimitrios Tousoulis(National and Kapodistrian University of Athens), Johanna Contreras, Khaled M. Ziada, Bryan Batson, Joachim Weil
Cited by 775
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k